Justin Meiklem

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Vancouver, British Columbia and Rehovot, Israel – October 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology process, today announced that management has been invited to attend  the LD Micro Main Event XVII Conference taking place on October 30, 2024. CEO Ilan Sobel […]

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024 Read More »

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

Vancouver, British Columbia and Rehovot, Israel – September 20, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company’s management team, continuing to serve as Vice President of Investor Relations of

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board Read More »

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Vancouver, British Columbia and Rehovot, Israel – September 12, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024. CEO Ilan Sobel

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024 Read More »

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Vancouver, British Columbia and Rehovot, Israel – September 4, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 – 10, 2024 at the Lotte New

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference Read More »

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+ Vancouver, British Columbia and Rehovot, Israel – August 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results Read More »

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA® Inside

Vancouver, British Columbia and Rehovot, Israel – August 28 , 2024 – – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee,  a “functional” coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA® Inside Read More »